锺邑林 医师 Yih-Lin Chung

放射肿瘤科
参与医疗团队: 大肠直肠癌团队, 妇癌团队, 头颈癌及鼻咽癌团队, 泌尿系癌团队, 软组织、骨骼肉瘤及皮肤癌团队, 神经系癌团队

专长:

  • 放射肿瘤
  • 分子生物

学历:

  • 美国密西根大学遗传硕士 (1995.07-1997.06)
  • 阳明大学 医学系 医学士 (1984.10-1991.06 )

现职:

  • 和信治癌中心医院 放射肿瘤科 主治医师专研医师 1999.11~迄今

经历:

  • 美国密西根大学 分子医学科 博士生及研究助理 1995.07~1997.08
  • 台北荣总 癌病中心外科 住院医师 1997.09~1999.10

专业学会:

  • 放射线学会
  • 放射肿瘤学会

着作:

  1. Chung YL, and Tsai TY. Promyelocytic Leukemia Nuclear Bodies Link the DNA Damage Repair Pathway with Hepatitis B Virus Replication: Implications for Hepatitis B Virus Exacerbation during Chemotherapy and Radiotherapy. Mol Cancer Res 7(10):1672-1685, 2009.
  2. Chung YL, Lee MY, and Pui MN. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Carcinogenesis 30(8):1387-1397, 2009.
  3. Chung YL, Lee MY, Horng CF, Jian JJ, Cheng SH, Tsai SY, Hsieh CI, Yen LK, and Lin CY. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Head Neck 31(1):9-20, 2009.
  4. Chung YL, James Jer-Min Jian, Skye Hongiun Cheng, Stella Y.C. Tsai, Vincent P. Chuang, Thomas Soong, Yu-Mong Lin, Cheng-Fang Horng. Sublethal Irradiation Induces Vascular Endothelial Growth Factor and Promotes Growth of Hepatoma Cells: Implications for Radiotherapy of Hepatocellular Carcinoma. Clinical Cancer Research 12(9): 2706-2715, 2006.
  5. Chung, YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, and Tsou MH. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Gynecologic Oncology 97: 126-135, 2005.
  6. Chung YL, Wang AJ, and Yao LF. Antitumor Histone Deacetylase Inhibitors Suppress Cutaneous Radiation Syndrome: Implications for Increasing Therapeutic Gain in Cancer Radiotherapy. Molecular Cancer Therapeutics 3(3): 317-325, 2004.
  7. Chung YL, Lee MY, Wang AJ, and Yao LF. A Therapeutic Strategy Uses Histone Deacetylase Inhibitors to Modulate the Expression of Genes Involved in the Pathogenesis of Rheumatoid Arthritis. Molecular Therapy: The Official Journal of the American Society of Gene Therapy 8(5): 707-717, 2003.
  8. Chung YL, Sheu ML, and Yen SH. Hepatitis C Virus NS5A as a Potential Viral Bcl-2 Homologue Interacts with Bax and Inhibits Apoptosis in Hepatocellular Carcinoma. International Journal of Cancer 107(1): 65-73, 2003.
  9. Chung YL, Sheu ML, Yang SC, Lin CH, and Yen SH. Resistance to Tamoxifen-induced Apoptosis is Associated with Direct Interaction between Her2/neu and Cell Membrane Estrogen Receptor in Breast Cancer. International Journal of Cancer 97(3):306-312, 2002.
  10. Chung YL, Lee Wu YH, Yen SH, and Chi KW. A Novel Approach for Nasopharyngeal Carcinoma Treatment Uses Phenylbutyrate as a Protein Kinase C Modulator: Implications for Radiosensitization and Epstein-Barr Virus-Targeted Therapy. Clinical Cancer Research 6(4):1452-1458, 2000.
  11. Hu G, Chung YL, Glover T, Valentine V, Look AT, Fearon ER. Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics 46(1):103-111, 1997.
     
TOP
Copyright © 医疗财团法人辜公亮基金会和信治癌中心医院 台湾 台北市北投区立德路125号 电话:(02) 2897-0011 / (02) 6603-0011